Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colonic Neoplasms × avelumab × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Penile Neoplasms 1 PD-L1 Positive Mutation Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 Hemangiosarcoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Anus Neoplasms 1

Interventions

Fluorouracil 31 Leucovorin 28 Oxaliplatin 22 Irinotecan 17 Folfox protocol 9 Chemotherapy, Adjuvant 9 Cetuximab 9 Capecitabine 8 Bevacizumab 8 Neoadjuvant Therapy 7 Drug Therapy 7 XELOX 6 Laparoscopy 6 Endoscopic Mucosal Resection 5 Colonoscopy 4 Celecoxib 4 Radiotherapy 3 Preoperative Exercise 3 Colectomy 3 Aspirin 3 raltitrexed 2 Tegafur 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sodium Chloride 2 Simvastatin 2 S 1 (combination) 2 Rivaroxaban 2 Polymerase Chain Reaction 2 Panitumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03608046 2020-10-22

AVETUXIRI

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡